Impact of Virtual Reality on Painful Menstruation
Launched by NEW ISMAILIA NATIONAL UNIVERSITY · Apr 28, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how virtual reality (VR) can help relieve painful menstruation, also known as dysmenorrhea, in adolescent girls. The researchers want to see if using VR can make the experience of menstrual pain more bearable and improve relaxation during this time.
To participate in this study, girls aged 16 to 22 who experience painful menstruation and have a normal body weight (a body mass index between 20 and 25) can join. However, girls with certain conditions, such as polycystic ovarian syndrome, obesity, or severe menstrual bleeding, won't be eligible. If you decide to take part, you can expect to use virtual reality technology during your menstrual cycle to see if it helps reduce pain and improve your overall comfort. This study is currently recruiting participants, so it's a great chance to contribute to research that could help many young women.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • age from 16 to 22 year
- • cases of primary dysmenorrhea
- • Normal body mass index (20-25)
- Exclusion Criteria:
- • cases with polycystic ovarian syndrome
- • Obese female or body mass index more than 25
- • severe bleeding with menstruation
- • cases with low back pain due to orthopedic origin like disc herniation or spinal malalignment
About New Ismailia National University
New Ismailia National University is a leading educational and research institution dedicated to advancing healthcare through innovative clinical trials. With a focus on fostering collaboration between academic expertise and clinical practice, the university aims to enhance medical knowledge and improve patient outcomes. By conducting rigorous research and adhering to the highest ethical standards, New Ismailia National University contributes to the development of new therapeutic strategies and the evaluation of existing treatments, ultimately striving to address pressing health challenges in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ismailia, , Egypt
Amman, , Jordan
Patients applied
Trial Officials
Hadeel MA Badwan, Ph.D
Study Chair
Al Zaytona University in Jordon
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported